The Worldwide Insomnia Industry is Projected to Reach $6.3 Billion by 2030 - ResearchAndMarkets.com

The "Insomnia Market By Therapy Type: Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering.

The global insomnia market was valued at $ 4,318.9 million in 2020, and is projected to reach $ 6,315.9 million by 2030, registering a CAGR of 3.9% from 2021 to 2030.

Insomnia is a sleep disorder wherein people find it difficult to sleep or remain asleep. The symptoms for insomnia include, low stamina, daytime sleepiness, depression, and irritability. It is a highly prevalent disorder that affects millions of people globally. Insomnia-related conditions are caused due to disruption in circadian rhythm, chronic pain, hyperthyroidism, menopause, psychological stress, and other medical conditions. This disorder can be diagnosed in sleep laboratories by using various diagnostic devices.

The global insomnia market is expected to register substantial growth in the near future, owing to rise in depression and sleep disorders in growing number of population. For instance, according to World Health Organization (WHO), approximately 280 million population across the globe were diagnosed with depression in 2020. People diagnosed with depression usually suffer from insomnia and excessive thinking.

Furthermore, rise in stress levels among youngsters have affected the quality of sleep and hence, led to an increase in growth of the insomnia market. However, side effects caused due to excessive use of sleep medication are expected to hamper the market growth during the forecast period. Conversely, increase in funding for R&D activities in the sleep disorders sector is expected to offer remunerative opportunities for market players.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the insomnia market analysis from 2020 to 2030 to identify the prevailing insomnia market opportunity.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the insomnia market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• The report includes the analysis of the regional as well as global insomnia market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Therapy Type

• Non pharmacological Therapy
• Pharmacological Therapy

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• Japan
• China
• Australia
• India
• South Korea
• Taiwan
• Rest of Asia-Pacific
• LAMEA
• Brazil
• Turkey
• Saudi Arabia
• Republic Of South Africa
• Rest of LAMEA

Key Market Players

• Currax Pharmaceuticals LLC
• Eisai Co Ltd
• Merck
• Minerva Neurosciences Inc
• Pfizer Inc.
• Sanofi
• Takeda Pharmaceutical Company Ltd
• Vanda Pharmaceuticals Inc.
• Viatris INC
• Zydus Cadila

For more information about this report visit https://www.researchandmarkets.com/r/y2tidc

View source version on businesswire.com: https://www.businesswire.com/news/home/20221018005702/en/